SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-007395
Filing Date
2022-05-04
Accepted
2022-05-04 16:20:10
Documents
72
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q gbt-20220331.htm   iXBRL 10-Q 2941272
2 EX-31.1 gbt-ex31_1.htm EX-31.1 16682
3 EX-31.2 gbt-ex31_2.htm EX-31.2 16772
4 EX-32.1 gbt-ex32_1.htm EX-32.1 14174
  Complete submission text file 0000950170-22-007395.txt   10685597

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gbt-20220331_def.xml EX-101.DEF 240768
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gbt-20220331_lab.xml EX-101.LAB 488794
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gbt-20220331.xsd EX-101.SCH 54700
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gbt-20220331_pre.xml EX-101.PRE 398095
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gbt-20220331_cal.xml EX-101.CAL 56027
66 EXTRACTED XBRL INSTANCE DOCUMENT gbt-20220331_htm.xml XML 2227094
Mailing Address 181 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080
Business Address 181 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080 650741-7700
Global Blood Therapeutics, Inc. (Filer) CIK: 0001629137 (see all company filings)

IRS No.: 274825712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37539 | Film No.: 22891789
SIC: 2834 Pharmaceutical Preparations